MedPath

FGBOU VO KUBGMU MINZDRAVA ROSSII, FGBU

🇷🇺Russia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:0

Trial Phases

2 Phases

Phase 2:1
Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (66.7%)
Phase 2
1 (33.3%)

Reconstruction of the Pelvic Floor and Perineal Wound After Rectal ELAPE

Not Applicable
Not yet recruiting
Conditions
Rectum Cancer
First Posted Date
2023-10-04
Last Posted Date
2023-10-10
Lead Sponsor
Kuban State Medical University
Target Recruit Count
150
Registration Number
NCT06066931

Luteal Phase Support With Daily Administration of Gonadotropin-releasing Hormone Agonist Compared to Progesterone/Estradiol in IVF/ICSI Cycles With Ovulation Triggering With GnRH-a

Phase 2
Conditions
Infertility
Interventions
Drug: Gonadotropin-releasing hormone agonist
First Posted Date
2021-12-03
Last Posted Date
2021-12-03
Lead Sponsor
Kuban State Medical University
Target Recruit Count
102
Registration Number
NCT05143723
Locations
🇷🇺

Alisa Baklakova, Krasnodar, Krasnodar Krai, Russian Federation

Laryngo-Tracheal Tissue-Engineered Clinical Transplantation

Not Applicable
Conditions
Tracheal Diseases
First Posted Date
2013-11-28
Last Posted Date
2016-03-07
Lead Sponsor
Kuban State Medical University
Target Recruit Count
6
Registration Number
NCT01997437
Locations
🇷🇺

Clinical Regional Hospital #1, Krasnodar, Russian Federation

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.